These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32886765)

  • 1. Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis.
    Pirillo A; Svecla M; Catapano AL; Holleboom AG; Norata GD
    Cardiovasc Res; 2021 Mar; 117(4):1033-1045. PubMed ID: 32886765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary lipid modification for mild and severe dyslipidaemias.
    Marais AD
    Proc Nutr Soc; 2013 Aug; 72(3):337-41. PubMed ID: 23680392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic factors influencing lipoprotein structure: implications for atherosclerosis.
    Chan L; Dresel HA
    Lab Invest; 1990 May; 62(5):522-37. PubMed ID: 2160560
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of genetic factors in the modulation of postprandial lipemia.
    Perez-Martinez P; Lopez-Miranda J; Perez-Jimenez F; Ordovas JM
    Atheroscler Suppl; 2008 Sep; 9(2):49-55. PubMed ID: 18603482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of modified lipoprotein in the development of atherogenic dyslipidaemia].
    Zvenigorodskaia LA; Churikova AA
    Eksp Klin Gastroenterol; 2011; (11):73-8. PubMed ID: 22629724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated proteomics and metabolomics analysis reveals differential lipid metabolism in human umbilical vein endothelial cells under high and low shear stress.
    Venturini G; Malagrino PA; Padilha K; Tanaka LY; Laurindo FR; Dariolli R; Carvalho VM; Cardozo KHM; Krieger JE; Pereira ADC
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C326-C338. PubMed ID: 31067084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocytosis of lipoproteins.
    Zanoni P; Velagapudi S; Yalcinkaya M; Rohrer L; von Eckardstein A
    Atherosclerosis; 2018 Aug; 275():273-295. PubMed ID: 29980055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia.
    Chan DC; Barrett PH; Watts GF
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):369-85. PubMed ID: 24840265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein sialylation in atherosclerosis: Lessons from mice.
    Yu L; Peng J; Mineo C
    Front Endocrinol (Lausanne); 2022; 13():953165. PubMed ID: 36157440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
    Vaziri ND
    Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
    Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein metabolism and atherosclerosis susceptibility in transgenic mice.
    Breslow JL
    Curr Opin Lipidol; 1994 Jun; 5(3):175-84. PubMed ID: 7952911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative modification of lipoproteins.
    Arai H
    Subcell Biochem; 2014; 77():103-14. PubMed ID: 24374922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
    Park JG; Xu X; Cho S; Lee AH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Receptor endocytosis of polyenic acids: sensitivity and resistance to atherosclerosis (review of the literature)].
    Titov VN
    Klin Lab Diagn; 1999 Jan; (1):3-8. PubMed ID: 10097487
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma lipoproteins: genetic influences and clinical implications.
    Hegele RA
    Nat Rev Genet; 2009 Feb; 10(2):109-21. PubMed ID: 19139765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern methods of diagnosis dyslipidemia ].
    Sukhorukov VN; Karagodin VP; Orekhov AN
    Patol Fiziol Eksp Ter; 2016; 60(1):65-72. PubMed ID: 29215251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid and lipoprotein metabolism].
    Wächtershäuser A; Stein J
    Pharm Unserer Zeit; 2007; 36(2):98-107. PubMed ID: 17424994
    [No Abstract]   [Full Text] [Related]  

  • 20. Dietary supplementation with long-chain monounsaturated fatty acid isomers decreases atherosclerosis and alters lipoprotein proteomes in LDLr
    Yang ZH; Gordon SM; Sviridov D; Wang S; Danner RL; Pryor M; Vaisman B; Shichijo Y; Doisaki N; Remaley AT
    Atherosclerosis; 2017 Jul; 262():31-38. PubMed ID: 28486149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.